Elevai Labs Inc. is implementing a 1-for-200 reverse stock split to maintain Nasdaq listing

From GlobeNewswire: 2024-11-22 18:23:00

Elevai Labs Inc. (NASDAQ: ELAB) will implement a 1-for-200 reverse stock split of its common stock effective November 27, 2024, to meet Nasdaq’s minimum bid price requirement. Shareholders do not need to take immediate action, and fractional shares will be adjusted accordingly. The stock symbol remains “ELAB” with a new CUSIP number. This move aims to maintain Elevai’s Nasdaq listing, enhance visibility, and bolster investor confidence. Post-split, approximately 3.07 million shares will be outstanding. CEO Graydon Bensler emphasizes the company’s commitment to innovation and value creation. For more information, refer to Elevai’s Form 8-K filing or contact [email protected].



Read more at GlobeNewswire: Elevai Labs Inc. Announces Reverse Stock Split to Maintain